Vaccine Development and Immunization
Vaccines are among the most effective tools in medicine, preventing millions of deaths every year. Vaccine development creates new and better vaccines, while immunisation programmes make sure they reach the people who need them.
The Vaccine Development and Immunization session at Infectious 2027 covers vaccine science and delivery. It links closely with microbiology and immunology, which explains how vaccines train the immune system.
Vaccines train the immune system to fight infections before they cause illness. They protect not only individuals but also those around them. Developing a vaccine takes many years of research and testing. Delivering it fairly to everyone who needs it is just as important.
Key Topics in Vaccine Development and Immunization
• mRNA and new vaccine platforms
• Vaccine design and antigen selection
• Clinical trials of vaccines
• Vaccine safety monitoring
• Immunisation programmes and coverage
• Vaccine hesitancy and confidence
• Vaccines for older adults and pregnant women
• Vaccines for neglected and emerging diseases
• Vaccine supply and equity
• Correlates of protection
Recent Advances in Vaccine Development and Immunization
mRNA platforms allow vaccines to be designed and updated quickly, as seen with COVID-19, and are now being tested for many other infections. New vaccines for RSV, malaria and dengue are expanding protection, linking with malaria and other protozoan diseases.
Vaccine hesitancy is a challenge in many countries, and research from psychosocial aspects of infectious disease management is helping build confidence. Fair global access is a key theme in global health and infectious diseases.
mRNA and other new platforms are allowing faster vaccine development. New vaccines are protecting against diseases such as RSV, malaria and dengue. Research on vaccine confidence is helping programmes reach more people. Global efforts are working to improve fair access to vaccines.
Who Should Attend the Vaccine Development and Immunization Session
• Vaccinologists and immunologists
• Immunisation programme managers
• Public health professionals
• Paediatricians and primary care staff
• PhD students and early-career researchers
• Vaccine industry and regulatory teams
Why Present Your Research in Vaccine Development and Immunization
Presenting at Infectious 2027 puts your vaccine research in front of an international audience. You can connect with colleagues in emerging and re emerging infectious diseases preparing vaccines for future threats. Vaccine research touches science, policy and public health. Presenting here helps your work reach all these audiences.
Frequently Asked Questions
Can I present vaccine hesitancy research?
Yes. Vaccine confidence and uptake are key topics.
Does this session include early-stage vaccine research?
Yes. Preclinical and early clinical vaccine studies are welcome.
When is Infectious 2027?
Infectious 2027 runs from 11 to 13 March 2027 at Village Hotel Changi, Singapore, and online.